Viagra experienced no effect on saquinavir pharmacokinetics. A stronger CYP3A4 inhibitor for example ketoconazole or itraconazole may be predicted to have better influence than that viewed with saquinavir. Populace pharmacokinetic information from individuals in medical trials also indicated a reduction in sildenafil clearance when it had been co-a